These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Apoptosis: the central actor in the three hits that trigger anti-neutrophil cytoplasmic antibody-related systemic vasculitis. Esnault VL Nephrol Dial Transplant; 2002 Oct; 17(10):1725-8. PubMed ID: 12270975 [No Abstract] [Full Text] [Related]
24. The antineutrophil cytoplasmic antibody-associated vasculitides. Seo P; Stone JH Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387 [TBL] [Abstract][Full Text] [Related]
25. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis. Almroth G; Berlin G; Andersson B; Hahn-Zoric M Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374 [TBL] [Abstract][Full Text] [Related]
26. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Koukoulaki M; Jayne DR Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784 [TBL] [Abstract][Full Text] [Related]
27. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy? Flossmann O; de Groot K Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358 [No Abstract] [Full Text] [Related]
29. Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis. Harper L Curr Opin Rheumatol; 2010 Jan; 22(1):37-42. PubMed ID: 19770660 [TBL] [Abstract][Full Text] [Related]
30. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. McGregor JG; Negrete-Lopez R; Poulton CJ; Kidd JM; Katsanos SL; Goetz L; Hu Y; Nachman PH; Falk RJ; Hogan SL Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i171-81. PubMed ID: 25805747 [TBL] [Abstract][Full Text] [Related]
31. Lack of awareness of skin cancer among immunocompromised patients with antineutrophil cytoplasmic antibody-associated vasculitis: a questionnaire survey. Ali FR; Brown N; Lear JT; Helbert M; Bruce IN; Venning MC Br J Dermatol; 2014 Jul; 171(1):193-5. PubMed ID: 24484377 [No Abstract] [Full Text] [Related]
32. [Goodpasture syndrome associated with p-ANCA microscopic vasculitis: a rare entity to recognize]. Pralong G; Fournier C; Dayer E; Meier P Rev Med Suisse; 2009 Jun; 5(207):1330-4. PubMed ID: 19626934 [TBL] [Abstract][Full Text] [Related]
33. [Immunology in clinical practice IX. Systemic vasculitis]. Kallenberg CG; Tervaert JW Ned Tijdschr Geneeskd; 1998 Jan; 142(3):118-23. PubMed ID: 9557008 [TBL] [Abstract][Full Text] [Related]